Globe on Blue Background with abstract mountains

2021 World Conference on Lung Cancer News

Read coverage from the WCLC 2021. WCLC 2021 news features updates from before, during, and after the meeting.
blue background with colorful dots surrounding lungs

IASLC 2021 Hot Topic Meeting: Small Cell Lung Cancer October 29-30, 2021

Registration is now open for the IASLC 2021 Hot Topic Meeting: Small Cell Lung Cancer (SCLC 2021). Register on or before October 1, 2021 for early bird savings.
Globe on Blue Background with abstract mountains

Thank you for attending the IASLC 2021 World Conference on Lung Cancer September 8-14, 2021

All recordings are available for viewing through December 17, 2021.
2021 World Conference on Lung Cancer News
IASLC 2021 Hot Topic Meeting: Small Cell Lung Cancer October 29-30, 2021
Thank you for attending the IASLC 2021 World Conference on Lung Cancer September 8-14, 2021

Homepage

The International Association for the Study of Lung Cancer

The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.

Explore More

In Focus

Get social Join the conversation

IASLC 2021 World Conference on Lung Cancer

Join the largest international gathering of clinicians, researchers, and scientists in the field of lung cancer from September 8-14, 2021. 

Kristin Richiemer

Kristin Richeimer, CAE, DES named IASLC Interim Chief Executive Officer

The Board of Directors of the International Association for the Study of Lung Cancer (IASLC) is pleased to announce the appointment of Kristin Richeimer, CAE, DES to the position of Interim Chief Executive Officer, effective immediately.

Language Guide page 1

IASLC Language Guide

In line with the IASLC Equity Statement and in step with the ASCO Language of Respect, we are proud to announce the release of the IASLC Language Guide. The guide was established to instill best practices with commonly used phrases related to patient care. The IASLC will be folding the language found in the guide into all aspects of thoracic oncology education, from abstracts to faculty guidelines to podium presentations. 

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

See More

Our Work

The IASLC Staging Project

The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, mesothelioma, thymic and esophageal cancer.

Lung Ambition Alliance

The IASLC has formed an alliance with three other founding organizations to allow scientists, specialists, advocates, and patients to break the barriers limiting progress and double 5-year survival rates of lung cancer by 2025.

In Numbers

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
45
Years Experience
15K
Number of Research Awards Funded
15.609
JTO Impact Factor
8K+
Members

Upcoming Meetings & Webinars

IASLC Meeting
Oct 29 - Oct 30 2021
IASLC Meeting
Dec 03 - Dec 04 2021
IASLC Meeting
Feb 23 - Feb 25 2022
JTO-CRR_Hero-0820 - Cropped.jpg

Journal of Thoracic Oncology & JTO Clinical and Research Reports

Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.